(E)-1-[5-[2-(4-acetylphenyl)acetyl]-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;methyl N-[4-[2-[2-chloro-6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-nitro-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate
C144H122Cl6N36O24 — CID 158074415
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-1-[5-[2-(4-acetylphenyl)acetyl]-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;methyl N-[4-[2-[2-chloro-6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-nitro-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate
(E)-1-[5-[2-(4-acetylphenyl)acetyl]-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;methyl N-[4-[2-[2-chloro-6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-nitro-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate (PubChem CID 158074415) has the molecular formula C144H122Cl6N36O24 and a molecular weight of 2953.51 g/mol. Its IUPAC name is (E)-1-[5-[2-(4-acetylphenyl)acetyl]-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;methyl N-[4-[2-[2-chloro-6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-nitro-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate.
Molecular Properties
| Compound Name | (E)-1-[5-[2-(4-acetylphenyl)acetyl]-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;methyl N-[4-[2-[2-chloro-6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-nitro-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate |
|---|---|
| PubChem CID | 158074415 |
| Molecular Formula | C144H122Cl6N36O24 |
| Molecular Weight | 2953.51 g/mol |
| Exact Mass | 2948.76 |
| IUPAC Name | (E)-1-[5-[2-(4-acetylphenyl)acetyl]-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;methyl N-[4-[2-[2-chloro-6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-8,8-dimethyl-3-nitro-5,7-dihydro-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate;methyl N-[4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-nitro-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]phenyl]carbamate |
| SMILES | CC(=O)c1ccc(CC(=O)C2c3cc([N+](=O)[O-])cnc3C(C)(C)CN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.CC(=O)c1ccc(CC(=O)C2c3cccnc3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.COC(=O)Nc1ccc(CC(=O)C2c3cc([N+](=O)[O-])cnc3C(C)(C)CN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.COC(=O)Nc1ccc(CC(=O)C2c3cc([N+](=O)[O-])cnc3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.COC(=O)Nc1ccc(CC(=O)C2c3ccc(Cl)nc3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1 |
| InChI | InChI=1S/C30H27ClN8O6.C30H26ClN7O5.C28H23Cl2N7O4.C28H23ClN8O6.C28H23ClN6O3/c1-30(2)16-37(26(41)11-6-19-13-20(31)7-10-24(19)38-17-33-35-36-38)27(23-14-22(39(43)44)15-32-28(23)30)25(40)12-18-4-8-21(9-5-18)34-29(42)45-3;1-18(39)20-6-4-19(5-7-20)12-26(40)28-24-14-23(38(42)43)15-32-29(24)30(2,3)16-36(28)27(41)11-8-21-13-22(31)9-10-25(21)37-17-33-34-35-37;1-41-28(40)32-20-6-2-17(3-7-20)14-24(38)27-21-8-10-25(30)33-22(21)12-13-36(27)26(39)11-4-18-15-19(29)5-9-23(18)37-16-31-34-35-37;1-43-28(40)32-20-6-2-17(3-7-20)12-25(38)27-22-14-21(37(41)42)15-30-23(22)10-11-35(27)26(39)9-4-18-13-19(29)5-8-24(18)36-16-31-33-34-36;1-18(36)20-6-4-19(5-7-20)15-26(37)28-23-3-2-13-30-24(23)12-14-34(28)27(38)11-8-21-16-22(29)9-10-25(21)35-17-31-32-33-35/h4-11,13-15,17,27H,12,16H2,1-3H3,(H,34,42);4-11,13-15,17,28H,12,16H2,1-3H3;2-11,15-16,27H,12-14H2,1H3,(H,32,40);2-9,13-16,27H,10-12H2,1H3,(H,32,40);2-11,13,16-17,28H,12,14-15H2,1H3/b11-6+;11-8+;11-4+;9-4+;11-8+ |
| InChIKey | FMERTXIUJOILKU-JACIPJJKSA-N |
| XLogP | 21.10 |
| TPSA | 747.90 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 49 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 210 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2953.51 |
| LogP ≤ 5 | 21.10 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 49 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158074415 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.